Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results from the TANDEM Trial

Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure

Cerebrospinal Fluid and Plasma Concentrations of Ubrogepant in Participants with a History of Migraine

Author:Boinpally, Ramesh   Trugman, Joel   

Session Name:P5: Headache: Advances in CGRP Inhibition 1  

Topic:Headache  

Program Number:P5.008  

Author Institution:AbbVie, North Chicago, IL  Abbvie, Moraga, CA